Radisys Celebrates Six Engage Digital Platform Winners of TADHack 2022 Hackathon
8.11.2022 22:30:00 EET | Business Wire | Press release
Radisys® Corporation, a global leader of open telecom solutions, is pleased to highlight the winners of the Engage Digital Platform real-world solutions in the 2022 TADHack Global, a hackathon focused on programmable communication solutions. Radisys provided participants in the Telecom Application Development (TAD) with access to its award-winning, no-code or low-code Engage Digital Platform to develop software projects or “hacks” that address customer challenges or use cases. Radisys’ Engage Digital Platform provides developers with a complete toolkit to create a full range of communication services, from voice and video calling, speech analytics and robust conversational AI-enabled digital engagement solutions.
The TADHack Global hackathon took place October 15-16, 2022, with participants competing across several cities and online. Radisys selected six winners, including a tie for third place and two specialized categories, for the best hacks from among the 23 submissions using Radisys’ Engage Digital Platform.
“I want to congratulate all of the 2022 TADHack Global event winners, especially those teams that leveraged Radisys’ Engage Digital Platform to develop such innovative solutions,” said Al Balasco, Head of Media, Core and Applications Business, Radisys. “The development of these amazing real-world solutions over a weekend was impressive and underscores the speed at which new ideas and applications can be developed and implemented. Hackathons like TADHack are a great way to showcase how MSPs and system integrators can benefit from an innovative developer ecosystem that is equipped with APIs and SDKs to create powerful advanced media applications they can integrate and offer as new services.”
Engage Digital Platform TADHack Global Winners
- First Place – Field Workforce Helper provides information from the inventory to support field workforce tasks, and routes Guard calls to the guard operator using an agenda in a Google spreadsheet, finally logging the call information in the spreadsheet. Team Member: Nacho Garmilla.
- Second Place – Secret Babble makes multilingual conversations more accessible by providing translations over the phone which can be read out loud by the system or sent discreetly as a text message, providing a transcription of the exchange. Team: Similarly Geeky; Team Members: Steve Goodwin & Lily Madar.
- Third Place – Blink is an application for crowded places designed to reduce the crowd and give people easy access to information about that particular place. It is used in places like hospitals, banks, shops, and airports, etc. Team: Sibane IT Solutions; Team Member: Linda Mosemaka.
- Third Place – Live Connect lets users connect to experts around the world for things such as learning a new language or finding a math or music tutor, to getting golf swing help and anything in between. Live Connect helps users find a suitable expert, book an appointment and connect via computer or phone using Radisys video APIs to bring the expert into customers’ homes. Team: Live Connect; Team Member: John Cakesy.
- Best Industry 4.0 Hack – FiremeX is a fire detection and alerting system that integrates computer vision, alert notifications and real-time audio calling when an event is detected. Team: RegeX; Team members: Nandula Perera, Raveen Fernando, Suvin Kodituwakku, Dilan Perera, Thenuka Ovin Weerasinghe.
- Disruptive Digital Engagement Hack – LifeVerse is a real-time health engagement platform that enables different types of clinics to be created and managed in the metaverse for both appointments and real-time consultations with patients. Team: LifeVerse; Team Members: Fahad Mahmood, Sarmad Faheem, Faheem Azhar.
To view videos of the six Engage Digital Platform winners and see all of the TADHack 2022 hacks visit https://www.engagedigital.ai/tadhack22.
About Radisys
Radisys, a global leader in open telecom solutions, enables service providers to drive disruption with new open architecture business models. Radisys’ innovative disaggregated and virtualized enabling technology solutions leverage open reference architectures and standards, combined with open software and hardware to power business transformation for the telecom industry, while its world-class services organization delivers systems integration expertise necessary to solve communications and content providers’ complex deployment challenges. For more information, visit www.radisys.com.
Radisys Engage Digital Platform was named both a 2022 Unified Communications Product of the Year Award winner and a Communications Product of the Year Award winner by TMC, a global, integrated media company covering multiple markets within the communications and technology industries, and won the Innovation in Digital Experience award in the 2022 Pipeline Innovation Awards, which recognizes the leading innovators transforming the industry with the most significant technological advancements. Engage Digital Platform was also named a “Highly Commended Best Comms Software” by the 2022 Comms Council UK Awards, a celebration of innovation in the telecom industry, and was selected as a finalist in the Best CPaaS Platform Award category by UC Today, a leading online publication for unified communications (UC) and collaboration technology. For more information, visit www.engagedigital.ai.
Radisys® is a registered trademark of Radisys. All other trademarks are the property of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221108006102/en/
Contact information
Nereus for Radisys
Matt Baxter, +1-503-619-0505
radisys@nereus-worldwide.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 09:10:00 EEST | Press release
LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across systems, identify root causes, and execute actions within governed guardrails. iRun combines AI agents and human expertise to shift opera
Azafaros to Present at BIO International Convention 202615.6.2026 08:00:00 EEST | Press release
Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 07:05:00 EEST | Press release
Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making. “Black Recon
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
